Nanotechnology for Neurological Disorders: Application of Nanotechnology in Diagnosing and Treating Neurodegenerative Diseases

Nanotechnology is applied for diagnosing and treating neurodegenerative diseases such as Parkinson’s and Alzheimer’s presents riveting opportunities. Targeted drug delivery systems that can cross the blood-brain barrier also known as the BBB can be developed, and there can be particular biomarkers that help in enabling early diagnosis and monitoring of diseases. Additionally, nanotechnology offers potential solutions for improving the delivery of therapeutics to the brain for Alzheimer's disease. The impact of Parkinson's and Alzheimer's diseases worldwide, the current issues in treating these diseases, and how nanotechnology can help develop innovative treatments targeting the underlying mechanisms of these diseases for more effective interventions in the future. Nanotechnology uses nanoparticles which are being used increasingly in various medical fields, including drug delivery, and disease diagnosis. The use of nanoparticles in medicine has shown great promise in the treatment of multiple diseases, specifically neurodegenerative disorders, such as Alzheimer's and Parkinson's disease. The unique properties of nanoparticles are their small size but large surface area, making them ideal for targeted drug delivery.